Results 201 to 210 of about 48,268 (246)

Influenza Vaccine Effectiveness in Australia During 2017-2019. [PDF]

Influenza Other Respir Viruses
Diefenbach-Elstob T, Chilver MB, Spirkoska V, Carville KS, Dapat C, Turra M, Tran T, Deng YM, Peck H, Barr IG, Stocks N, Sullivan SG.   +11 more
europepmc   +1 more source

Global update on the susceptibilities of influenza viruses to neuraminidase inhibitors and the cap-dependent endonuclease inhibitor baloxavir, 2020-2023.

Antiviral Res
Hussain S, Meijer A, Govorkova EA, Dapat C, Gubareva LV, Barr IG, Brown SK, Daniels RS, Fujisaki S, Galiano M, Huang W, Kondor RJ, Lackenby A, Lewis N, Lo J, Nguyen HT, Patel MC, Pereyaslov D, Rattigan A, Samaan M, Wang D, Webby RJ, Yen HL, Zhang W, Takashita E.   +24 more
europepmc   +1 more source

Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025

Kikawa C, Huddleston J, Loes AN, Turner SA, Lee J, Barr IG, Cowling BJ, Englund JA, Greninger AL, Harvey R, Hasegawa H, Ho F, Lacombe K, Leung NH, Lewis NS, Peck H, Watanabe S, Smith DJ, Bedford T, Bloom JD.   +19 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Magnetic Particle Spectroscopy (MPS) for Detection of Influenza A Virus Subtype H1N1.

ACS Applied Materials & Interfaces, 2020
Magnetic nanoparticles (MNPs) with proper surface functionalization have been extensively applied as labels for magnetic immunoassays, carriers for controlled drug/gene delivery, tracers and contrasts for magnetic imaging, etc.
Kai Wu, Jinming Liu, Renata Saha, Diqing Su, V. Krishna, M. Cheeran, Jianping Wang   +6 more
semanticscholar   +3 more sources

Drug Design for the Influenza A Virus Subtype H1N1

2009 2nd International Conference on Biomedical Engineering and Informatics, 2009
Chien-Yu Chen, D. Bau, M. Tsai, Y. Hsu, T. Ho, Hung-Jin Huang, Yea-Huey Chang, F. Tsai, Chang-Hai Tsai, Calvin Yu‐Chian Chen   +9 more
semanticscholar   +3 more sources

Drug design for Influenza A virus subtype H1N1

Journal of the Taiwan Institute of Chemical Engineers, 2010
Abstract An outbreak of influenza A virus subtype H1N1, also known as swine flu, in Mexico was occurred in April 2009. To design drugs for treating this epidemic is urgency. In this study, we employed the new sequences (2009) to build the N1 simulation structure by homology modeling, which has been checked for high reliability by Verify Score and ...
Chien-Yu Chen, Hung-Jin Huang, F. Tsai, Calvin Yu‐Chian Chen   +3 more
semanticscholar   +3 more sources

Influenza virus A subtype H1N1 is inhibited by methylated β-lactoglobulin

Journal of Dairy Research, 2010
Addition of methylated β-lactoglobulin (Met-BLG) in the medium of MDCK cell lines infected with influenza virus subtype H1N1 reduced hemagglutination activity (HA) in a concentration dependent manner. Antiviral activity of Met-BLG depended on its concentration, viral load, and duration of infection. Using 17 μg/ml of Met-BLG inhibited 50% of HA of H1N1
Sitohy, Mahmoud Zaki, Scanu, Michela, Besse, Bernard, Mollat, Claudine, Billaudel, Sylviane, Haertlé, Thomas, Chobert, Jean-Marc   +6 more
openaire   +5 more sources

Thrombotic thrombocytopenic purpura triggered by influenza A virus subtype H1N1 infection

Transfusion and Apheresis Science, 2012
We report a case of acquired thrombotic thrombocytopenic purpura (TTP) triggered by influenza A virus subtype H1N1 infection. In December 2010, a 27-year-old man was diagnosed with pneumonia from influenza A virus infection at a local clinic.
Young Rae Koh, Sang-Hyun Hwang, Chulhun L. Chang, Han Chul Son, Eun Yup Lee, Hyung Hoi Kim   +5 more
openaire   +3 more sources